Preview

Rational Pharmacotherapy in Cardiology

Advanced search

E-cigarette Smoking (Vaping) and Markers of Vascular Wall Damage in Young Subjects without Cardiovascular Disease

https://doi.org/10.20996/1819-6446-2021-08-04

Full Text:

Abstract

Aim: to investigate the effect of nicotine-containing vapes in comparison with traditional tobacco smoking on markers of vascular wall damage: high sensitivity C-reactive protein (hsCRP), albuminuria (AU), and ankle-brachial index (ABI).

Material and Methods: We examined 369 young subjects without cardiovascular diseases (age median 21 [20;21] years) (159 men and 210 women). The hsCRP levels in the serum were assessed by immunochromatographic express method. AU was investigated in daily urine by a quantitative reflex photometry. ABI was determined by plethysmography.

Results: All subjects were divided into groups: non-smokers (n=196, 53.1%), smokers of traditional cigarettes (n=83, 22.5%) and smokers of nicotine-containing vapes (n=90, 24.4%). The groups did not differ in main anthropometric data. Median hsCRP levels in smokers (14.30 [11; 16.5] mg/l in tobacco-smokers and 13.15 [9.65; 17.5] mg/l in vapers) were significantly higher vs nonsmokers (3.0 [2; 5.6] mg/l). In tobacco-smokers (33.0  [21.5;  60]  mg)  and  vape  smokers  (45.0  [20;  115]  mg),  the  median  AU  was  statistically  significantly  higher  than  in  non-smokers  (12.0 [10; 20] mg). ABI levels were significantly lower in the groups of tobacco smokers (0.98 [0.91; 0.99]) and vapers (0.85 [0.79; 0.93]) when compared with nonsmokers (1.125 [1.01; 1.18]), and the median ABI in vapers was lower than in tobacco smokers (p<0.001). In the group of tobacco smokers, the hsCRP level correlated with the smoker's index (rs=0.31, p<0.05), and AU (rs=0.54, p<0.05) and ABI (rs=-0.28, p<0.05) with a daily inhaled nicotine dose. In the group of vapers, CRP was associated with smoking experience (rs=0.338, p<0.05), AU with a daily inhaled nicotine dose (rs=0.79,  p<0.05), and  ABI with  BMI (rs=-0.33,  p<0.05), heart  rate (rs=-0.24,  p<0.05) and  smoking experience  (rs=-0.235, p<0.05). According to the results of multivariate regression analysis the hsCRP level was related with only the smoking experience (B=0.91±0.19, p=0.000005), AU level with the daily inhaled nicotine dose (B=1.59±0.7, p=0.0121) and smoking experience (B=3.07±1.23, p=0.0179), and ABI level with only smoking experience (B=-0.09±0.004, p=0.0419).

Conclusion: In smokers, both traditional and vapers, the levels of hsCRP, AU are significantly higher, and the ABI is lower than in healthy young nonsmokers. The most significant influence on the level of hsCRP is exerted by the experience of  tobacco  and  vape  smoking;  to  the  AU  level  – the experience of tobacco and vaping and the daily inhaled nicotine dose, and by the value of the ABI – the experience of vaping.

About the Authors

V. I. Podzolkov
I.M. Sechenov First Moscow State Medical University
Russian Federation

[Valery I. Podzolkov

eLibrary  SPIN  8683-2155

Moscow



A. E. Bragina
I.M. Sechenov First Moscow State Medical University
Russian Federation

Anna E. Bragina

eLibrary SPIN SPIN 3753-5539

Moscow



N. A. Druzhinina
I.M. Sechenov First Moscow State Medical University
Russian Federation

Natalia A. Druzhinina

eLibrary   SPIN   6842-0447

Moscow



L. N. Mohammadi
University of California
United States

Leila Mohammadi

San Francisco, California



References

1. Miech R, Johnston L, O'Malley PM, et al. Trends in 534 Adolescent Vaping, 2017-2019. N Engl J Med. 2019;381(15):1490-1. DOI:10.1056/NEJMc1910739.

2. World Health Organization The tobacco atlas [cited by Jun 29, 2021]. Available from: http://www.tobaccoatlas.org/.

3. Sack MN, Fyhrquist FY, Saijonmaa OJ, et al. Basic Biology of Oxidative Stress and the Cardiovascular System: Part 1 of a 3-Part Series. J Am Coll Cardiol. 2017;70(2):196-211. DOI:10.1016/j.jacc.2017.05.034.

4. Kondo T, NakanoY, Adachi S, Murohara T. Effects of Tobacco Smoking on Cardiovascular Disease. Circ J. 2019;83(10):1980-5. DOI:10.1253/circj.CJ-19-0323.

5. El-Kenawi A, Ruffell B. Inflammation, ROS, and Mutagenesis. Cancer Cell. 2017;32:727-9. DOI:10.1016/j.ccell.2017.11.015.

6. Haptonstall KP, Choroomi Y, Moheimani R, et al. Differential effects of tobacco cigarettes and electronic cigarettes on endothelial function in healthy young people. Am J Physiol Heart Circ Physiol. 2020;319(3):547-56. DOI:10.1152/ajpheart.00307.2020.

7. Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol. 2014;34:509-15. DOI:10.1161/ATVBAHA.113.300156.

8. Carnevale R, Sciarretta S, Violi F, et al. Acute Impact of Tobacco vs Electronic Cigarette Smoking on Oxidative Stress and Vascular Function. Chest. 2016;150:606-12. DOI:10.1016/j.chest.2016.04.012.

9. Forstermann U, Xia N, Li H. Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis. Circ Res. 2017;120:713-35. DOI:10.1161/CIRCRESAHA.116.309326.

10. Munzel T, Camici GG, Maack C, et al. Impact of Oxidative Stress on the Heart and Vasculature: Part 2 of a 3-Part Series. J Am Coll Cardiol. 2017;70:212-29. DOI:10.1016/j.jacc.2017.05.035.

11. Hall ME, Wang W, Okhomina V, et al. Cigarette smoking and chronic kidney disease in African Americans in the Jackson Heart Study. J Am Heart Assoc. 2016;5:e003280. DOI:10.1161/JAHA.116.003280.

12. Podzolkov VI, Bragina AE, Druzhinina NA, et al. Relation between Tobacco Smoking/ Electronic Smoking and Albuminuria/Vascular Stiffness in Young People without Cardiovascular Diseases. Kidney Blood Press Res. 2020;45:467-76. DOI:10.1159/000507510.

13. Gupta R, Maheshwari VD, Mawliya M. Impact of smoking on microalbuminuria and urinary albumin creatinine ratio in non-diabetic normotensive smokers. Indian J Nephrol. 2014;24(2):92-6. DOI:10.4103/0971-4065.127893.

14. Ishtiaque I, Shafique K, U-HaqZ, et al.Water-Pipe Smoking and Albuminuria: New Dog with Old Tricks. PLoS One. 2014;9(1):e85652. DOI:10.1371/journal.pone.0085652.

15. Hackshaw A, Morris JK, Boniface S, et al. Low cigarette consumption and risk of coronary heart disease and stroke: Meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018;360:5855. DOI:10.1136/bmj.j5855.

16. Middlekauff HR. Cardiovascular impact of electronic-cigarette use Trends. Cardiovasc Med.2020;30(3):133-140. DOI:10.1016/j.tcm.2019.04.006.

17. Moheimani RS, Bhetraratana M, Peters KM, et al. Sympathomimetic effects of acute e-cigarette use: role of nicotine and non-nicotine constituents. J Am Heart Assoc. 2017;6(9):e006579. DOI:10.1161/JAHA.117. 006579.

18. Moheimani RS, Bhetraratana M, Yin F, et al. Increased cardiac sympathetic activity and oxidative stress in habitual electronic cigarette users: implications for cardiovascular risk. JAMA Cardiol. 2017;2(3):278-84. DOI:10.1001/jamacardio.2016.5303.

19. Antoniewicz L, Bosson JA, Kuhl J, et al. Electronic cigarettes increase endothelial progenitor cells in the blood of healthy volunteers. Atherosclerosis. 2016;255:179–85 DOI:10.1093/cvr/cvz256.

20. Vlachopoulos C, Ioakeimidis N, Abdelrasoul M, et al. Electronic cigarette smoking increases aortic stiffness and blood pressure in young smokers. J Am Coll Cardiol. 2016;67(23):2802-3. DOI:10.1016/j.jacc.2016.03.569.

21. Dinardo P, Rome ES. Vaping: The new wave of nicotine addiction. Cleve Clin J Med. 2019;86(12):78998. DOI:10.3949/ccjm.86a.19118.

22. Buchanan ND, Grimmer JA, Tanwar V, et al. Cardiovascular risk of electronic cigarettes: a review of preclinical and clinical studies. Cardiovasc Res. 2020;116(1):40-50. DOI:10.1093/cvr/cvz256.

23. Chaumont M, Tagliatti V, Channan EM, et al. Short halt in vaping modifies cardiorespiratory parameters and urine metabolome: a randomized trial. Am J Physiol Lung Cell Mol Physiol. 2020;318(2):331-44. DOI:10.1152/ajplung.00268.2019.


For citation:


Podzolkov V.I., Bragina A.E., Druzhinina N.A., Mohammadi L.N. E-cigarette Smoking (Vaping) and Markers of Vascular Wall Damage in Young Subjects without Cardiovascular Disease. Rational Pharmacotherapy in Cardiology. 2021;17(4):521-527. https://doi.org/10.20996/1819-6446-2021-08-04

Views: 346


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)